Zobrazeno 1 - 10
of 18
pro vyhledávání: '"U N PETROVA"'
Autor:
D A SHASHELEVA, A A MASCHAN, L N SHELIKHOVA, U N PETROVA, E E KURNIKOVA, O I ILLARIONOVA, E V BOYAKOVA, G A NOVICHKOVA, M A MASCHAN
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk
Externí odkaz:
https://doaj.org/article/c5aa744b838d4ea0acb3b3e7f77cb253
Autor:
G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)
Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The
Externí odkaz:
https://doaj.org/article/a539b74b2830479ca8268ed25335826e
Autor:
G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-15 (2022)
Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are ana
Externí odkaz:
https://doaj.org/article/aff35ebb6ec14d3cbe54f0f6a680cf5f
Autor:
N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-13 (2022)
Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are inc
Externí odkaz:
https://doaj.org/article/b5947a60a3844a338c3bdb12bb102b9d
Autor:
L. A. Khachatrian, M. A. Maschan, Ye. V. Samochatova, M. M. Schneider, D. D. Baidildina, G. G. Solopova, Ye. V. Suntzova, L. I. Zjarikova, U. N. Petrova, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 34-38 (2022)
Prognosis of patients with juvenile myelomonocytic leukemia not undergoing allogeneic hematopoietic cells transplantation (SCT) is dismal and not affected by any cytotoxic chemotherapy. Differentiating therapy is an attractive approach in JMML, due t
Externí odkaz:
https://doaj.org/article/fd2660cb6eaf48aa8f9d1014cd95ecab
Autor:
A. K. Ignatova, I. I. Kalinina, D. A. Venev, T. Yu. Salimova, D. A. Evseev, M. N. Sadovskaya, O. V. Goronkova, V. E. Matveev, U. N. Petrova, K. S. Antonova, D. D. Baydildina, M. E. Dubrovnaya, T. V. Konyukhova, Yu. V. Olshanskaya, D. S. Abramov, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 10-22 (2021)
Background. Extramedullary infiltration (EI) is relatively common in children with acute myeloid leukemia (AML) (up to 20-25 %). However, its clinical and prognostic significance remains poorly understood.Objective: to describe clinical features and
Externí odkaz:
https://doaj.org/article/14fb36d0acc24523992dfb11fa1cebf2
Autor:
M. Kh. Gurzhikhanova, G. I. Shestopalov, M. S. Vasilyeva, U. N. Petrova, K. S. Antonova, D. V. Fedorova, N. N. Kotskaya, S. A. Radygina, L. B. Lubsanova, E. K. Donyush, O. S. Fink, E. A. Pristanskova, E. V. Skorobogatova, A. V. Pavlova, M. A. Kurnikova, E. V. Suntsova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:65-76
Mutations in the MECOM gene (MDS1 and EVI1 complex locus) may be one of the causes of a rare combination of congenital radioulnar synostosis resulting in extremely limited forearm pronation and supination, and amegakaryocytic thrombocytopenia. The cl
Autor:
A. Ya. Avedova, I. V. Mersiyanova, A. V. Pavlova, E. R. Sultanova, U. N. Petrova, D. N. Balashov, L. N. Shelikhova, E. V. Raykina, D. E. Pershin, A. V. Pshonkin, D. V. Fedorova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:126-135
Conditions associated with defects in the SAMD9/SAMD9L genes represent a relatively new group of diseases characterized by a diverse range of clinical manifestations: from multisystem disorders such as MIRAGE syndrome to isolated hematological manife
Autor:
I. I. Kalinina, D. A. Venyov, Yu. V. Olshanskaya, M. N. Sadovskaya, O. V. Goronkova, T. Yu. Salimova, U. N. Petrova, D. D. Baidildina, E. V. Suntsova, D. A. Evseev, V. E. Matveev, K. S. Antonova, I. G. Khamin, M. Е. Dubrovina, E. A. Zerkalenkova, M. V. Gaskova, A. M. Popov, S. A. Kashpor, A. I. Mandzhieva, T. V. Konyukhova, L. A. Khachatryan, D. V. Litvinov, D. N. Balashov, L. N. Shelikhova, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:20-35
Over the past years, the outcomes of patients with acute myeloid leukemia (AML) have significantly improved due to the use of intensive chemotherapy, more effective supportive therapy, and the availability of allogeneic hematopoietic stem cell transp
Autor:
Z. A. Kuzminova, M. N. Korsantya, U. N. Petrova, D. V. Fedorova, M. N. Sadovskaya, A. V. Pshonkin, N. M. Trubina, N. N. Kotskaya, O. N. Mironenko, T.Yu. Salimova, Elena V. Suntsova, Alexey Maschan, I.I. Kalinina, G. S. Ovsyannikova, D.D. Baydildina, Galina Novichkova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:12-25
Thrombopoietin receptor agonists (TPO-RA) – romiplostim and eltrombopag – changed considerably the therapeutic options for severe persistent and chronic immune thrombocytopenia (ITP). The article presents the results of a retrospective study of T